AstraZeneca's fast-rising diabetes med Farxiga jumps into the COVID-19 fray

23rd April 2020 Uncategorised 0

AstraZeneca’s high-profile SGLT2 diabetes med Farxiga is looking at a bright future with big FDA decisions in heart failure and kidney disease right around the corner. Now, the British drugmaker is testing it as a potential coronavirus therapy, too.

More: AstraZeneca's fast-rising diabetes med Farxiga jumps into the COVID-19 fray
Source: fierce